pd 98059 has been researched along with Adrenal Cortex Cancer in 3 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Duursen, MB | 1 |
| Nijmeijer, SM | 1 |
| Ruchirawat, S | 1 |
| van den Berg, M | 1 |
| Lin, CI | 1 |
| Whang, EE | 1 |
| Moalem, J | 1 |
| Ruan, DT | 1 |
| Watanabe, M | 1 |
| Noda, M | 1 |
| Nakajin, S | 1 |
3 other studies available for pd 98059 and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
Topics: 4-Butyrolactone; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Cell Cycle; Cell Line, Tumor; E | 2010 |
Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
Topics: Adrenal Cortex Neoplasms; Alprostadil; Aromatase; Benzylamines; Cell Line, Tumor; Dinoprost; Dinopro | 2006 |